{
  "id": 135801,
  "title": "Otsuka succeeds with kidney drug; BioNTech downgrades revenue projection",
  "url": "https://urgent.news/2026/08/04/otsuka-succeeds-with-kidney-drug-biontech-downgrades-revenue",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-04T14:50:59.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/otsuka-succeeds-with-kidney-drug-biontech-downgrades-revenue-projection/"
  },
  "original_language": "en",
  "account": null,
  "summary": "✅ Otsuka’s confirmatory kidney disease data: The drugmaker said Voyxact met a key secondary endpoint in the Phase 3 VISIONARY study in patients with IgA nephropathy (IgAN). The treatment increased the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}